Drugs that target dynamic microtubules: A new molecular perspective

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Medicinal research reviews (Print)

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/med.20242PMID 21381049PMCID PMC3155728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.

  2012cited by this paper
• Colchicine Binding to Sea Urchin Eggs and the Mitotic Apparatus

  2011cited by this paper
• Microtubule Dynamics

  2011cited by this paper
• A novel microtubule-modulating noscapinoid triggers apoptosis by inducing spindle multipolarity via centrosome amplification and declustering

  2011cited by this paper
• New microtubule-inhibiting anticancer agents

  2010influential reference
• Oncogenic function of microtubule end‐binding protein 1 in breast cancer

  2010cited by this paper
• Non‐toxic melanoma therapy by a novel tubulin‐binding agent

  2010cited by this paper
• A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.

  2010cited by this paper
• Kinesin-14 family proteins HSET/XCTK2 control spindle length by cross-linking and sliding microtubules.

  2009cited by this paper
• MCAK and paclitaxel have differential effects on spindle microtubule organization and dynamics.

  2009cited by this paper
• Regulation of microtubule dynamic instability.

  2009cited by this paper
• Variations in the colchicine-binding domain provide insight into the structural switch of tubulin

  2009cited by this paper
• Microtubule dynamics as a target in oncology.

  2009influential reference
• Combretastatin-like chalcones as inhibitors of microtubule polymerisation. Part 2: Structure-based discovery of alpha-aryl chalcones.

  2009cited by this paper
• EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells

  2009cited by this paper
• Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.

  2009cited by this paper
• Mammalian end binding proteins control persistent microtubule growth

  2009cited by this paper
• Tracking the ends: a dynamic protein network controls the fate of microtubule tips

  2008cited by this paper
• Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

  2008cited by this paper
• Tubulin-interactive natural products as anticancer agents.

  2008cited by this paper
• Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin

  2008cited by this paper
• Structural insight into the inhibition of tubulin by vinca domain peptide ligands

  2008cited by this paper
• Microtubule Active Agents: Beyond the Taxane Frontier

  2008cited by this paper
• Straight GDP-tubulin protofilaments form in the presence of taxol.

  2007cited by this paper
• Peloruside A synergizes with other microtubule stabilizing agents in cultured cancer cell lines.

  2007cited by this paper
• Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent

  2007cited by this paper
• The human kinesin Kif18A is a motile microtubule depolymerase essential for chromosome congression.

  2007cited by this paper
• Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

  2007cited by this paper
• Microtubule-Associated Proteins as Targets in Cancer Chemotherapy

  2007cited by this paper
• In vitro and in vivo anticancer activities of synthetic (-)-laulimalide, a marine natural product microtubule stabilizing agent.

  2007cited by this paper
• Structure and thermodynamics of the tubulin-stathmin interaction.

  2007cited by this paper
• Single-walled tubulin ring polymers.

  2007cited by this paper
• The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells.

  2007cited by this paper
• p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.

  2007cited by this paper
• Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.

  2006cited by this paper
• Rational design of the microtubule-targeting anti-breast cancer drug EM015.

  2006cited by this paper
• Plus end-specific depolymerase activity of Kip3, a kinesin-8 protein, explains its role in positioning the yeast mitotic spindle

  2006cited by this paper
• Structural mechanisms underlying nucleotide-dependent self-assembly of tubulin and its relatives.

  2006cited by this paper
• Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro*

  2006cited by this paper
• Microtubules, leukemia, and cough syrup

  2006cited by this paper
• Yeast kinesin-8 depolymerizes microtubules in a length-dependent manner

  2006cited by this paper
• Tau Protects Microtubules in the Axon from Severing by Katanin

  2006cited by this paper
• Synergistic Effects of Peloruside A and Laulimalide with Taxoid Site Drugs, but Not with Each Other, on Tubulin Assembly

  2006cited by this paper
• Treatment of hormone-refractory breast cancer: apoptosis and regression of human tumors implanted in mice

  2006cited by this paper
• Microtubule-targeting agents in angiogenesis: where do we stand?

  2006cited by this paper
• Drug-resistant T-lymphoid tumors undergo apoptosis selectively in response to an antimicrotubule agent, EM011.

  2006cited by this paper
• Development of a Novel Nitro-Derivative of Noscapine for the Potential Treatment of Drug-Resistant Ovarian Cancer and T-Cell Lymphoma

  2006cited by this paper
• Synthesis and biological evaluation of a cyclic ether fluorinated noscapine analog.

  2006cited by this paper
• Structural basis for the regulation of tubulin by vinblastine

  2005cited by this paper
• TIP maker and TIP marker; EB1 as a master controller of microtubule plus ends

  2005influential reference
• Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly.

  2005cited by this paper
• Proteomic identification of differentially‐expressed genes in human gastric carcinomas

  2005cited by this paper
• A comparison of the ability of XMAP215 and tau to inhibit the microtubule destabilizing activity of XKCM1

  2005cited by this paper
• On the road to cancer: aneuploidy and the mitotic checkpoint

  2005cited by this paper
• Targeting microtubules for cancer chemotherapy.

  2005cited by this paper
• Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating β-catenin/TCF pathway

  2005cited by this paper
• CLASP1 and CLASP2 bind to EB1 and regulate microtubule plus-end dynamics at the cell cortex

  2005cited by this paper
• Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.

  2005cited by this paper
• Proteomic study of human hepatocellular carcinoma using two‐dimensional difference gel electrophoresis with saturation cysteine dye

  2005cited by this paper
• The KinI kinesin Kif2a is required for bipolar spindle assembly through a functional relationship with MCAK

  2004cited by this paper
• Epothilones: mechanism of action and biologic activity.

  2004cited by this paper
• Noscapine Crosses the Blood-Brain Barrier and Inhibits Glioblastoma Growth

  2004cited by this paper
• MCAK, a Kin I kinesin, increases the catastrophe frequency of steady‐state HeLa cell microtubules in an ATP‐dependent manner in vitro

  2004cited by this paper
• Cortical control of microtubule stability and polarization.

  2004cited by this paper
• Centrosome maturation: measurement of microtubule nucleation throughout the cell cycle by using GFP-tagged EB1.

  2004cited by this paper
• Microtubules as a target for anticancer drugs

  2004influential reference
• Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain

  2004influential reference
• Microtubule-interacting drugs for cancer treatment.

  2003cited by this paper
• Microtubules, microtubule-interfering agents and apoptosis

  2003influential reference
• Tubulin rings: which way do they curve?

  2003cited by this paper
• The role of ABC transporters in clinical practice.

  2003cited by this paper
• 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

  2003cited by this paper
• Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.

  2003cited by this paper
• Phase 2 study of cryptophycin 52 (LY355703) in patients previously treated with platinum based chemotherapy for advanced non-small cell lung cancer.

  2003cited by this paper
• Combretastatins: from natural products to drug discovery.

  2003cited by this paper
• Antimicrotubular drugs binding to vinca domain of tubulin

  2003influential reference
• Tubulin and microtubules as targets for anticancer drugs.

  2003cited by this paper
• Vascular targeting effect of combretastatin A‐4 phosphate dominates the inherent angiogenesis inhibitory activity

  2003cited by this paper
• ACF7: an essential integrator of microtubule dynamics.

  2003cited by this paper
• The kinesin-related protein MCAK is a microtubule depolymerase that forms an ATP-hydrolyzing complex at microtubule ends.

  2003cited by this paper
• Distribution of the class II beta-tubulin in developmental and adult rat tissues.

  2002cited by this paper
• Natural products in cancer chemotherapy: past, present and future

  2002cited by this paper
• Cytoplasmic linker proteins promote microtubule rescue in vivo

  2002cited by this paper
• Minor Alteration of Microtubule Dynamics Causes Loss of Tension across Kinetochore Pairs and Activates the Spindle Checkpoint*

  2002cited by this paper
• INVESTIGATION OF DIVERSITY AND ISOTYPES OF THE BETA-TUBULIN cDNA IN SEVERAL SMALL STRONGYLE (CYATHOSTOMINAE) SPECIES

  2002cited by this paper
• Microtubule structure at 8 A resolution.

  2002cited by this paper
• A mechanism for microtubule depolymerization by KinI kinesins.

  2002cited by this paper
• Vascular targeting agents enhance chemotherapeutic agent activities in solid tumor therapy

  2002cited by this paper
• Paclitaxel-resistant Human Ovarian Cancer Cells Undergo c-Jun NH2-terminal Kinase-mediated Apoptosis in Response to Noscapine*

  2002cited by this paper
• Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton.

  2002cited by this paper
• Chromosome-microtubule interactions during mitosis.

  2002cited by this paper
• Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma.

  2002cited by this paper
• Sustained Activation of p34 cdc2 Is Required for Noscapine-induced Apoptosis*

  2001cited by this paper
• Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.

  2001cited by this paper
• Structural insight into microtubule function.

  2001influential reference
• The extended tubulin superfamily.

  2001cited by this paper
• BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

  2001cited by this paper
• Microtubule dynamics

  2001cited by this paper
• Physiochemical aspects of tubulin-interacting antimitotic drugs.

  2001cited by this paper
• Refined structure of alpha beta-tubulin at 3.5 A resolution.

  2001cited by this paper

• Investigating the Synergistic Effect of the Cannabis Extract PHEC-66 and Chemotherapeutic Agents on Human Melanoma Cells.

  2026cites this paper
• Discovery of Peptide-Based Tubulin Inhibitors Through Structure-Guided Design.

  2026cites this paper
• Investigation of heterocycle-fused 2,5-dihydro-1H-benzo[b][1,4]diazepine conjugate as potential anti-cancer agents: Design, synthesis and in silico docking activity

  2026cites this paper
• Impact of C-Terminal Amide N-Derivatization on the Conformational Dynamics and Antimitotic Activity of Cemadotin Analogues

  2026cites this paper
• Ergotamine-Loaded Nanoparticles for Targeting Microtubule Dynamics in Triple-Negative Breast Cancer Cells

  2026cites this paper
• The roundworm Ascaris: Recent advances on the road to elimination.

  2025cites this paper
• A class of benzofuranoindoline-bearing heptacyclic fungal RiPPs with anticancer activities

  2025cites this paper
• The Co-Administration of Paclitaxel with Novel Pyridine and Benzofuran Derivatives that Inhibit Tubulin Polymerisation: A Promising Anticancer Strategy

  2025cites this paper
• β‐Glucuronidase‐Responsive Albumin‐Binding Prodrug of Colchicine‐Site Binders for Selective Cancer Therapy

  2025cites this paper
• Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy.

  2025cites this paper
• Interplay Between Traditional and Scientific Knowledge: Phytoconstituents and Their Roles in Lung and Colorectal Cancer Signaling Pathways

  2025cites this paper
• Polyvalent immunoglobulin therapy: preclinical evidence and potential for treating chemotherapy-induced peripheral neuropathy

  2025cites this paper
• Peptide-based strategies for overcoming taxol-resistance in cancer therapy – a narrative review

  2025cites this paper
• Recent Advances in Microtubule Targeting Agents for Cancer Therapy

  2025cites this paper
• IBCar: Potent Orally Bioavailable Methyl N-[5-(3′-Iodobenzoyl)-1H-Benzimidazol-2-yl]Carbamate for Breast Cancer Therapy

  2025cites this paper
• Glycosaminoglycans Targeted by Colchicine in MCF-7 Cells

  2025cites this paper
• Design and synthesis of Cereblon-based PROTAC as novel potent degraders of α/β-tubulin

  2025cites this paper
• Innovative Peptide Therapeutics in the Pipeline: Transforming Cancer Detection and Treatment

  2025cites this paper
• Computational Design of New 3‐Phenoxy β‐Lactams as Tubulin Polymerization Inhibitors for Breast Cancer Therapy

  2025cites this paper
• Regenerative Hair Pigmentation via Skin Organoids: Adaptive Patterning Mediated by Collagen VI and Semaphorin 3C

  2025cites this paper
• Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer models

  2025cites this paper
• Natural-source Payloads used in the conjugated drugs architecture for cancer therapy: Recent advances and future directions.

  2024cites this paper
• A Novel Pyrazole Exhibits Potent Anticancer Cytotoxicity via Apoptosis, Cell Cycle Arrest, and the Inhibition of Tubulin Polymerization in Triple-Negative Breast Cancer Cells

  2024cites this paper
• Regulation of microtubule dynamics and function in living cells via cucurbit[7]uril host–guest assembly

  2024cites this paper
• Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer: Current Use and Future Prospects

  2024cites this paper
• Synthesis and modification of noscapine derivatives as promising future anticancer agents.

  2024cites this paper
• TUBB2B regulates epithelial-mesenchymal transition via interaction with Vimentin to promote glioma migration and invasion

  2024cites this paper
• Design and biological evaluation of dual tubulin/HDAC inhibitors based on millepachine for treatment of prostate cancer.

  2024cites this paper
• Data-Driven Equation-Free Dynamics Applied to Many-Protein Complexes: The Microtubule Tip Relaxation

  2024cites this paper
• Combretastatin A-4 based compounds as potential anticancer agents: A review.

  2024cites this paper
• MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial–mesenchymal transition in lung adenocarcinoma

  2024cites this paper
• Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC.

  2024cites this paper
• Synthesis, molecular docking analysis and in vitro evaluation of new heterocyclic hybrids of 4-aza-podophyllotoxin as potent cytotoxic agents

  2024cites this paper
• Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application.

  2024cites this paper
• Depolymerization of tubulin as the main molecular mechanism of the cytotoxic and antitumor activity of pyrrole-containing heterocyclic compounds

  2024cites this paper
• Microtubule polymerization induced by iridium‐fullerene photosensitizers for cancer immunotherapy via dual‐reactive oxygen species regulation strategy

  2024cites this paper
• Biomacromolecules as Immunomodulators: Utilizing Nature’s Tools for Immune Regulation

  2024cites this paper
• Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedside

  2024cites this paper
• Noscapine and Apoptosis in Breast and Other Cancers

  2024cites this paper
• Taxol (Paclitaxel): A Novel Alkaloid with Anticancer Potential

  2024cites this paper
• Synthesis, in silico, in vitro evaluation of furanyl- and thiophenyl-3-phenyl-1H-indole-2-carbohydrazide derivatives as tubulin inhibitors and anticancer agents.

  2024cites this paper
• mTOR inhibitor introduce disitamab vedotin (RC48-ADC) rechallenge microtubule-chemotherapy resistance in HER2-low MBC patients with PI3K mutation

  2024cites this paper
• The trimethoxyphenyl (TMP) functional group: a versatile pharmacophore

  2023cites this paper
• Cevipabulin induced abnormal tubulin protofilaments polymerization by binding to Vinblastine site and The Seventh site

  2023cites this paper
• Dual-targeting compounds possessing enhanced anticancer activity via microtubule disruption and histone deacetylase inhibition.

  2023cites this paper
• Antiproliferative Activity and Inhibition of Tubulin Polymerization

  2023cites this paper
• Effect of 2‐methoxyestradiol treatment on early‐ and late‐stage breast cancer progression in a mouse model

  2023cites this paper
• Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies

  2023cites this paper
• Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes

  2023cites this paper
• Biological evaluation of [4‐(4‐aminophenyl)‐1‐(4‐fluorophenyl)‐1H‐pyrrol‐3‐yl](3,4,5‐trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models

  2023cites this paper
• Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells

  2023cites this paper
• Synthesis, Modeling, and Biological Evaluation of Anti-Tubulin Indole-Substituted Furanones.

  2023cites this paper
• On the Simulation of Thermal Isomerization of Molecular Photoswitches in Biological Systems.

  2023cites this paper
• Transición epitelio – mesenquima y cáncer.

  2023cites this paper
• Taxol (Paclitaxel): A Promising Alkaloid for Cancer Treatment

  2023cites this paper
• Physiological and metabolic traits of Taxol biosynthesis of endophytic fungi inhabiting plants: Plant-microbial crosstalk, and epigenetic regulators.

  2023cites this paper
• Randomized controlled trial on the effect of 1‐hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)

  2023cites this paper
• Recent Progress on Microtubule Degradation Agents.

  2023cites this paper
• Reversible Photocontrol of Microtubule Stability by Spiropyran‐Conjugated Tau‐Derived Peptides

  2023cites this paper
• Development of hydrazide hydrazone-tethered combretastatin-oxindole derivatives as antimitotic agents

  2023cites this paper
• Systematic profiling of taxol and its analogues (taxalogues) binding to β‐tubulin and molecular analysis of their effects on microtubule stabilization

  2023cites this paper
• In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents

  2023influential citation
• Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options

  2023cites this paper
• Microtubules and Cell Division: Potential Pharmacological Targets in Cancer Therapy.

  2023cites this paper
• Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation

  2023influential citation
• Unveiling the Catalytic Mechanism of GTP Hydrolysis in Microtubules

  2023cites this paper
• Combined Biological and Numerical Modeling Approach for Better Understanding of the Cancer Viability and Apoptosis

  2023cites this paper
• Conversion to Trimolecular G-Quadruplex by Spontaneous Hoogsteen Pairing-Based Strand Displacement Reaction between Bimolecular G-Quadruplex and Double G-Rich Probes.

  2023cites this paper
• Isolation and Identification of Vincristine and Vinblastine Producing Endophytic Fungi from Catharanthus roseus (L.) G. Don

  2023cites this paper
• Drug Synergism of Anticancer Action in Combination with Favipiravir and Paclitaxel on Neuroblastoma Cells

  2023cites this paper
• Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities.

  2023cites this paper
• Unveiling the catalytic mechanism of GTP hydrolysis in microtubules

  2023cites this paper
• An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies

  2023cites this paper
• Computational-Based Discovery of the Anti-Cancer Activities of Pyrrole-Based Compounds Targeting the Colchicine-Binding Site of Tubulin

  2022cites this paper
• Protein oxidation marker, α-amino adipic acid, impairs proteome of differentiated human enterocytes: Underlying toxicological mechanisms.

  2022cites this paper
• Mast cell granule motility and exocytosis is driven by dynamic microtubule formation and kinesin-1 motor function

  2022cites this paper
• Colchicine May Interfere With the Efficacy of the Adenoviral Vector–Based Vaccine for COVID-19

  2022cites this paper
• Anti-tumor pharmacology of natural products targeting mitosis

  2022cites this paper
• Biomedicine & Pharmacotherapy

  2022cites this paper
• Kinetochore Architecture Employs Diverse Linker Strategies Across Evolution

  2022cites this paper
• SAR of Novel 3-Arylisoquinolinones: meta-Substitution on the Aryl Ring Dramatically Enhances Antiproliferative Activity through Binding to Microtubules

  2022cites this paper
• Design, synthesis, characterization and cytotoxic activity of new ortho-hydroxy and indole-chalcone derivatives against breast cancer cells (MCF-7)

  2022cites this paper
• Antimicrobial, Cytotoxicity and Molecular Docking Study of New Quinoline Schiff Base and its Metal(II) Complexes

  2022cites this paper
• ZnO Nanocomposites of Juniperus procera and Dodonaea viscosa Extracts as Antiproliferative and Antimicrobial Agents

  2022cites this paper
• Estrogens—Origin of Centrosome Defects in Human Cancer?

  2022cites this paper
• The G-Protein–Coupled Estrogen Receptor Agonist G-1 Inhibits Proliferation and Causes Apoptosis in Leukemia Cell Lines of T Lineage

  2022cites this paper
• Molecular Docking Analysis of Azadirachta Indica Phytocompounds against Androgen Receptor Protein for the Treatment of Prostate Cancer

  2022cites this paper
• Ginsenoside Rg5 Sensitizes Paclitaxel—Resistant Human Cervical-Adeno-Carcinoma Cells to Paclitaxel—And Enhances the Anticancer Effect of Paclitaxel

  2022cites this paper
• Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery.

  2022cites this paper
• Phytopharmacology of herbal biomolecules

  2022cites this paper
• Chalcogen bond-assisted syn-locked scaffolds: DFT analysis and biological implications of novel tubulin inhibitors.

  2022cites this paper
• Design, Synthesis, and Biological Evaluation of Novel Dihydropyrimidinone Derivatives as Potential Anticancer Agents and Tubulin Polymerization Inhibitors.

  2022cites this paper
• Nanoparticle Albumin-Bound Paclitaxel is More Effective Than Paclitaxel in Experimental Endometrial Cancer

  2022cites this paper
• Design, synthesis and biological evaluation of novel 2-phenyl-4,5,6,7-tetrahydro-1H-indole derivatives as potential anticancer agents and tubulin polymerization inhibitors

  2022cites this paper
• Modelling microtubule dynamic instability: Microtubule growth, shortening and pause.

  2022cites this paper
• Engineered Magnetic Polymer Nanoparticles Can Ameliorate Breast Cancer Treatment Inducing Pyroptosis-Starvation along with Chemotherapy.

  2022cites this paper
• Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities

  2022cites this paper
• Emodin Sensitizes Cervical Cancer Cells to Vinblastine by Inducing Apoptosis and Mitotic Death

  2022cites this paper
• Colchicine as A Potential Therapy in Hepatocellular Carcinoma: A Review

  2022cites this paper
• G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells

  2022influential citation